A Post-approval Observational Study to Evaluate the Long-term Effectiveness and Safety of Orkambi in US Patients who Completed Study VX12-809-105 Part A

Administered By

Awarded By

Contributors

Start/End

  • June 21, 2018 - December 24, 2019